Catalyst Pharmaceuticals, Inc.

Q4 2014 13F Holders

Symbol
CPRX
CUSIP
14888U101
Type
Equity
Class
COM
Num filings
52
Total reported value, excl. options
$81.3 M
Manager Report Date Value ($000) Shares Option Type